# Trade Mark Journal No.2026/034 21 August 2026

## WO0000001930991 (1,5,42,44)

Office of origin: Switzerland

Date of International Registration:9 April 2026
Date of designation in the UK: 9 April 2026

International priority date claimed: 20 October 2025 (Switzerland) (840245)

Class 1
  Active chemical ingredients used in the manufacture of cancer medicines and vaccines, medicines for treatment and prevention of dermatological or neurodegenerative diseases or disorders, as well as vaccines.
Class 5
  Pharmaceutical products, substances and preparations, in particular for treatment and prevention of cancer, dermatological or neurodegenerative diseases or disorders; medicinal preparations.
Class 42
  Scientific services; scientific advice and information services; preparation of scientific reports; medical research; scientific research, in particular for prevention and treatment of cancer, dermatological or neurodegenerative diseases or disorders.
Class 44
  Medical services, in particular for treatment and prevention of cancer, dermatological or neurodegenerative diseases or disorders; medical advice and information services; medical analysis services, in particular for diagnosis, treatment and prevention of cancer, dermatological or neurodegenerative diseases or disorders; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes; RNA or DNA analysis for prognosis and diagnosis of cancer, dermatological or neurodegenerative diseases or disorders; provision of information in the field of prevention, screening, diagnosis and treatment of cancers, dermatological or neurodegenerative diseases or disorders.

Torqur AG c/o Swiss Rockets AG

Representative: FMP Fuhrer Marbach & Partner, Konsumstrasse 16A,, Postfach, CH-3000 Bern 14, SWITZERLAND